Search
Close this search box.

Unveiling systemic triggers: Risk factors/indicators for peri-implantitis

Isabella Neme Ribeiro dos Reis, Nadja Naenni, Giuseppe Alexandre Romito, Cláudio Mendes Pannuti

Table of Contents

Introduction

Peri-implantitis is a widely prevalent condition. The complexity of its treatment, as well as the increased likelihood of recurrence, are challenging. Therefore, preventive measures and early diagnosis are fundamental in implant care, which includes managing risk indicators and factors. This review explores systemic factors associated with peri-implantitis development, focusing on smoking, hyperglycemia, and a history of periodontitis. Evidence from cohort studies indicates that smoking significantly increases the incidence of peri-implantitis, highlighting the dentist’s role in patient education and smoking cessation guidance. Evidence on the influence of hyperglycemia on increased risk of peri-implantitis from retrospective, cross-sectional, and cohort studies suggests an association between the two. While more consistent evidence from cohort studies is needed to establish hyperglycemia as a clear risk factor, the available evidence underscores its relevance as a risk indicator. Thus, dentists play an essential role in informing patients and collaborating with physicians in patient care. A history of periodontitis has also been associated with an increased risk of peri-implantitis, with conflicting evidence necessitating further investigation through cohort studies. Dentists must prioritize effective periodontitis management and control, particularly in patients with existing implants or needing implant procedures.

Why are preventive measures critically important in the realm of peri-implantitis?

Peri-implantitis is a disease associated with biofilm accumulation, characterized by inflammation in the peri-implant mucosa and loss of supporting bone (Berglundh et al., 2018). Its prevalence is estimated to be 22% (ranging from 1% to 47%) (Derks & Tomasi, 2015). The onset of peri-implantitis often occurs early, typically within three years of function, and its progression follows a non-linear and accelerating pattern (Derks et al., 2016).

Despite its prevalent occurrence, peri-implantitis poses a challenge due to the complex nature of therapeutic interventions and the sometimes limited effectiveness of its treatment (Heitz-Mayfield & Mombelli, 2014). Moreover, systematic reviews have brought attention to high recurrence rates following treatment of peri-implantitis. Investigations spanning three years of follow-up have shown recurrence rates of up to 69.9% for treated implants (Stiesch et al., 2023) and 100% in cases with follow-ups extending beyond one year (Esposito et al., 2012).

In this context, early diagnosis and prevention must be considered crucial aspects of implant dentistry. A preventive strategy involves managing both local and systemic risk factors to prevent the development or progression of peri-implantitis (Herrera et al., 2023; Jepsen et al., 2015; ITI Treatment Guide Volume 13).

Cumulative evidence has shown the association of certain factors with an increased risk of peri-implantitis (Darby, 2022). This article aims to provide evidence-based insights into the systemic factors associated with the development of peri-implantitis.

What defines a risk indicator and a risk factor for a disease?

A risk factor is any attribute, characteristic, or exposure of an individual that increases the likelihood of developing a disease. Risk factors are validated through a temporal sequence, often identified in cohort studies. Conversely, reducing or eliminating these factors often leads to a decreased risk of disease onset or progression (Beck, 1998).

Interventional longitudinal or cohort studies are needed to identify true risk factors for disease, while cross-sectional or retrospective studies may only highlight risk indicators (Schwarz et al., 2018). Causality in humans can be shown through randomized controlled trials, providing balance over potential prognostic factors between experimental and control groups via random assignment (Beck, 1998; Hill, 1949; Lilienfeld & Stolley, 1994). However, it is important to clarify that ethical and risk/benefit considerations restrict human experimentation. For example, it is unethical to assign people randomly to smoking and non-smoking groups to study disease development. Subjecting a patient to harm for the purpose of gathering evidence is not ethically defensible. For this reason, human experimental evidence is frequently unavailable to ascertain whether a factor causes disease. Interventional studies typically aim to demonstrate whether an intervention reduces disease incidence rather than increases disease occurrence rates (Beck, 1998; Hill, 1949; Lilienfeld & Stolley, 1994). Consequently, assessing the risk for disease is frequently conducted through prospective observational studies, such as cohort studies.

In the 2017 World Workshop for the classification of peri-implant diseases, potential risk factors and indicators for peri-implantitis were discussed. Among systemic risk factors and indicators, conditions such as smoking, diabetes, a history of periodontitis, genetic factors, cardiovascular disease, rheumatoid arthritis, osteoporosis, osteopenia, thyroid disease, hepatitis, body mass index, radiation, and chemotherapy were mentioned. However, smoking, diabetes, and a history of periodontitis were highlighted as having more robust evidence (Schwarz et al. 2018). The present article offers an updated perspective, focusing particularly on smoking, diabetes, and a history of periodontitis, which have more substantial evidence, incorporating new insights that have emerged.

Smoking

Despite worldwide health authorities’ extensive efforts to reduce smoking, the global number of smokers has actually increased (GBD Tobacco Collaborators et al., 2019). This implies that the number of smokers in dental offices is still rising. Additionally, new forms of smoking are emerging and being adopted by the population. Substantial evidence supports smoking as a significant risk factor for periodontitis and periodontitis-associated tooth loss (Carvalho et al., 2021; Leite et al., 2019).

Moreover, smoking significantly affects the peri-implant environment in several ways. It shifts the microbiome towards a state associated with disease (Pimentel et al., 2018; Tsigarida et al., 2015), induces vasoconstriction of gingival blood vessels, and hampers leukocyte function, increasing susceptibility to infection (Archana et al., 2015). Additionally, smoking disrupts the gene expression profile of mesenchymal stem cells, resulting in decreased osteogenic markers and an increase in pro-inflammatory genes, compromising bone metabolism (Cyprus et al., 2018). The inhalation of carbon monoxide diminishes hemoglobin’s oxygen-carrying capacity, potentially impeding healing and overall tissue health (Javed et al., 2019). Importantly, smoking triggers a cascade of systemic and local processes adversely affecting osteogenesis, bone metabolism, and the integrity of the bone-implant interface (Bezerra Ferreira et al., 2016; Pereira et al., 2010; Sayardoust et al., 2017).

Regarding the impact of smoking on the incidence of peri-implantitis, a recent systematic review and meta-analysis by Reis et al. revealed a significant increase in peri-implantitis rates among smokers (Reis et al., 2023). Compared to non-smokers, smokers faced twice the risk of developing peri-implantitis at the implant (RR: 2.04, 95% CI: 1.46–1.85) and at the patient level (RR: 2.08, 95% CI: 1.17–3.71). Importantly, this systematic review relied exclusively on cohort studies, allowing for the assessment of peri-implantitis development from the time of implant placement until the follow-up. The certainty of evidence, evaluated through the GRADE approach, was moderate for both patient and implant-level analyses, indicating a strong likelihood that the observed effects in the meta-analyses closely reflect the true impact (Reis et al., 2023).

The findings of this review contrast with those of previous reviews. Notably, this is the first to include only prospective cohort studies, while others encompassed cross-sectional and retrospective studies (Dreyer et al., 2018; Sgolastra et al., 2015; Turri et al., 2016).

The elevated risk of peri-implantitis in smokers (Reis et al., 2023) highlights the important role of dental professionals in informing patients with planned or existing dental implants about this relevant association. Additionally, it emphasizes the importance of providing guidance to encourage smoking cessation, thereby preventing possible biological complications.

Building on this discussion, it is important to note that the definition of a smoker can vary. However, even in studies where patients smoked fewer than 10 cigarettes daily, a notable incidence of peri-implantitis was observed in smokers. Therefore, it is advisable to use the Center for Disease Control and Prevention’s (CDC) definition of a smoker. According to this definition, current smokers are adults who have smoked 100 cigarettes in their lifetime and currently smoke every day or some days (CDC, 2017).

Diabetes/Hyperglycemia

An estimated 451 million people worldwide, aged 18-99 years, were living with diabetes in 2017. Projections indicate a substantial increase, with the global diabetic population expected to grow by approximately 242 million from 2017 to 2045. As a result, the projected total is set to reach 693 million by 2045 (Cho et al., 2018).

Epidemiological findings demonstrate a higher prevalence and severity of periodontitis in individuals with poorly controlled diabetes mellitus in contrast to healthy individuals. This link has prompted the consideration of periodontitis as a diabetes-associated complication, often referred to as “the sixth complication in diabetic patients” (Löe, 1993; Nibali et al., 2022).

Some mechanisms may explain the detrimental effects of hyperglycemia and diabetes on peri-implant tissues. Hyperglycemia induces hyper-inflammatory responses, resulting in increased tissue damage. Elevated blood glucose levels generate advanced glycation end products (AGEs). These AGEs activate the expression of receptors for AGEs (RAGEs), further impairing the repair of periodontal tissues. This impairment is exacerbated by the sustained inflammation induced by the bacterial biofilm (Lalla & Papapanou, 2011).

A systematic review and meta-analysis (Monje et al., 2017) investigated the potential association of diabetes and hyperglycemia with peri-implantitis. Seven studies had undergone quantitative analysis and the resulting meta-analyses indicated that the risk of peri-implantitis is roughly 50% higher in individuals with poorly controlled diabetes compared to those without diabetes (RR = 1.46; 95% CI: 1.21–1.77 and OR = 1.89; 95% CI: 1.31–2.46; z = 5.98; p < .001). Notably, among non-smokers, those with diabetes and hyperglycemia exhibited a 3.39-fold higher risk of peri-implantitis compared to those with normoglycemia (95% CI: 1.06–10.81). This systematic review suggests an association between diabetes mellitus/hyperglycemia and an increased risk of peri-implantitis, independently of smoking. In addition, the results suggest that the higher the glycemic level (i.e. poor glycemic control such as HbA1c >8%) at baseline, the greater prevalence of peri-implantitis (Monje et al., 2017). However, the review included retrospective, cross-sectional, and cohort studies and only two studies in the meta-analyses had a prospective design.
While valuable insights emerge, it is essential to acknowledge that including retrospective and cross-sectional studies precludes establishing a causal relationship due to the absence of a clear temporal connection. Despite the limitations, the findings of this review suggest an association between hyperglycemia and an increased risk of peri-implantitis.

In this context, dentists engaged in implant procedures should educate patients about the potential connection between poorly controlled diabetes and peri-implantitis. Furthermore, for individuals with poorly controlled diabetes, implant placement is associated with an unpredictable prognosis, delayed osseointegration, and a higher risk of failure (Tan et al. 2021). Open communication between dentists and physicians is crucial to ensure comprehensive care, considering diabetes management at every stage, from implant planning to maintenance. It is recommended to maintain an HbA1c level of <7.0–8.0% for diabetes control, depending on the patient’s systemic condition (Nathan et al. 2008).

History of periodontitis

A systematic review estimated the global prevalence of severe periodontitis in 2010 to have reached 10.8% (95% confidence interval: 10.1–11.6%). This condition affected 743 million people worldwide, ranking it as the sixth most widespread health issue (Kassebaum et al., 2014). Periodontitis is one of the main causes of tooth loss (Al-Shammari et al., 2005; Carvalho et al., 2021), indicating that a significant proportion of patients opting for dental implant placement after tooth loss will have a history of periodontitis.

A systematic review and meta-analysis analyzed the association between a history of periodontitis and peri-implantitis. Five studies were part of the meta-analysis, indicating that periodontally compromised patients had an increased risk of peri-implantitis compared to those without a history of periodontitis (RR: 2.21, 95% CI: 1.42–3.43, P=0.0004), with moderate but not significant heterogeneity (P=0.12;I2=46%). However, it is noteworthy that only one of the studies included in this analysis was prospective, while the others adopted a cross-sectional design (Sgolastra et al., 2015a).

A 10-year prospective study found a 6% peri-implantitis incidence (defined as PD ≥ 5 mm, BOP+, and annual bone loss >0.2 mm) in the non-periodontitis group at implant level, contrasting with a 29% incidence in individuals exhibiting a history of periodontitis (Karoussis et al., 2003). Costa et al. reported significantly higher odds of developing peri-implantitis in individuals with periodontitis (OR 9). During the investigated 5-year follow-up, 21 out of 27 patients with peri-implantitis had developed the condition. Six out of 7 in the group participating in regular maintenance appointments and 15 of 18 in the group enrolled in a regular maintenance program (Costa et al., 2012). Furthermore, a recent prospective study with a 20-year follow-up reported a significantly increased risk of peri-implantitis in patients with a history of periodontitis (40.3%) compared to periodontally healthy patients (13.6%) (p=0.025) (Roccuzzo et al. 2023). These cohort studies build upon previous follow-ups by Roccuzzo et al. (2010, 2012) that were included in the 2017 World Workshop review by Schwarz et al. This concluded that there is strong evidence supporting a history of periodontitis as a risk factor/indicator for peri-implantitis.

More recently, a systematic review and meta-analysis examined the influence of periodontitis on peri-implantitis development and found contrasting results (Ferreira et al., 2018). The review showed an association between the presence or history of periodontitis and peri-implantitis based on implant and patient-based data, with a 2.15 higher chance of developing peri-implantitis (95% CI: 1.10; 3.21). Nevertheless, this association was not replicated in the meta-analysis of cohort studies (N = 5) for patient-based or implant-based data (Ferreira et al., 2018). Additionally, more recently, a systematic review focusing solely on cohort studies (N = 5) found that the incidence of peri-implantitis was 4.09 times higher (95% CI: 1.93–8.58) in periodontally compromised patients compared to periodontally healthy patients at the implant level, with a follow-up period ranging from 5 to 20 years (Serroni et al., 2024).

However, the variability in diagnostic criteria for periodontitis and peri-implantitis in terms of defining form, severity, and extent complicated accurate evaluation in both reviews, hindering comparisons between studies. Moreover, different approaches to assessing periodontitis history may have introduced biases, potentially favoring patients with an “active” periodontitis history over those undergoing regular periodontal maintenance therapy. Studies comparing patients with a history of periodontitis to those with “active” disease are needed to discern potential disparities. Given the limited inclusion of only two cohort studies, caution is advised in interpreting the results until additional cohort studies are conducted. 

While additional cohort studies are necessary for further validation, the current focus should remain on proactive treatment and control of periodontitis to reduce the risk of peri-implantitis. Given that the history of periodontitis is an immutable aspect in patients, the primary focus for dentists should always be the effective management and control of the disease. It is imperative to prioritize periodontal health in patients with an ongoing disease or with a history of periodontitis, not only during the maintenance phase but even more so before implant placement.

Conclusion

In conclusion, prevention, and management of peri-implantitis should address the control of its risk indicators/factors, such as smoking, hyperglycemia, and history of periodontitis. The ongoing challenge of peri-implantitis, coupled with its high prevalence and recurrence rates, reinforces the need for continuous research on its risk factors, as well as updated strategies in both prevention and treatment to ensure peri-implant health.

Authors

Isabella Neme Ribeiro dos Reis
Isabella Neme Ribeiro dos Reis holds a specialist degree in Prosthodontics (2017), Implant Dentistry (2018), and Periodontics (2019) from the University of São Paulo (USP), Brazil. She earned her PhD at USP, with part of her doctoral studies conducted at Aarhus University, Denmark (2023). Currently, she is the ITI scholar at the Department of Reconstructive Dentistry at the University of Zurich (2023/2024). Additionally, she is a Postdoctoral student at USP.
Nadja Naenni
Nadja Naenni holds a specialist degree in reconstructive dentistry and a Master’s in Oral Implantology from the University of Zurich. In 2021, she was awarded the ‘Venia Legendi’ (PD) from the University of Zurich. Since 2013, she has been a full-time Senior Research and Teaching Assistant at the above clinic in Zurich, Switzerland, and spent one year (2017) in Malmö and Gothenburg as a guest researcher. She is the director of the postgraduate programme at the above clinic. She is a senior member of the interdisciplinary team for peri-implantitis.
Giuseppe Alexandre Romito
Giuseppe Romito received his D.D.S. in 1992 and his Certificate of Specialist in Periodontics in 1996. He got his Master’s in science in 1996 and his PhD in 2000, both in Periodontology from USP. He is the Head and Chair of the Periodontics Division, School of Dentistry, University of São Paulo (USP) – Brazil. He currently holds the position of vice dean of the School of Dentistry (2021-2025). He is the Director of the Certificate Program in Implantology and the Post-Graduation Program.
Cláudio Mendes Pannuti
Claudio Pannuti has a Degree in Dentistry (1993), a Master’s degree (1999), and a PhD (2001) in Periodontics from the University of São Paulo (USP). He has been a Professor at the University of São Paulo School of Dentistry since 2006. He has been a Full professor and Head of the Department of Stomatology since 2023. He has been a Statistical Advisor for the journal Clinical Oral Implants Research since 2020.

Al-Shammari, K. F., Al-Khabbaz, A. K., Al-Ansari, J. M., Neiva, R., & Wang, H.-L. (2005). Risk indicators for tooth loss due to periodontal disease. Journal of Periodontology, 76(11), 1910–1918. https://doi.org/10.1902/jop.2005.76.11.1910

Archana, M. S., Bagewadi, A., & Keluskar, V. (2015). Assessment and comparison of phagocytic function and viability of polymorphonuclear leukocytes in saliva of smokers and non-smokers. Archives of Oral Biology, 60(2), 229–233. https://doi.org/10.1016/j.archoralbio.2014.09.018

Beck, J. D. (1998). Risk revisited. Community Dentistry and Oral Epidemiology, 26(4), 220–225. https://doi.org/10.1111/j.1600-0528.1998.tb01954.x

Berglundh, T., Armitage, G., Araujo, M. G., Avila-Ortiz, G., Blanco, J., Camargo, P. M., Chen, S., Cochran, D., Derks, J., Figuero, E., Hämmerle, C. H. F., Heitz-Mayfield, L. J. A., Huynh-Ba, G., Iacono, V., Koo, K. T., Lambert, F., McCauley, L., Quirynen, M., Renvert, S., Salvi, G. E., … Zitzmann, N. (2018). Peri-implant diseases and conditions: Consensus report of workgroup 4 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. Journal of clinical periodontology, 45 Suppl 20, S286–S291. https://doi.org/10.1111/jcpe.12957

Bezerra Ferreira, J. D., Rodrigues, J. A., Piattelli, A., Iezzi, G., Gehrke, S. A., & Shibli, J. A. (2016). The effect of cigarette smoking on early osseointegration of dental implants: A prospective controlled study. Clinical Oral Implants Research, 27(9), 1123–1128. https://doi.org/10.1111/clr.12705

Carvalho, R., Botelho, J., Machado, V., Mascarenhas, P., Alcoforado, G., Mendes, J. J., & Chambrone, L. (2021). Predictors of tooth loss during long-term periodontal maintenance: An updated systematic review. Journal of Clinical Periodontology, 48(8), 1019–1036. https://doi.org/10.1111/jcpe.13488

Center for Disease Control and Prevention – National Center for Health Statistics. (2017). Tobacco glossary. The 29th of August, 2017. https://www.cdc.gov/nchs/nhis/tobacco/tobacco_glossary.htm

Cho, N. H., Shaw, J. E., Karuranga, S., Huang, Y., da Rocha Fernandes, J. D., Ohlrogge, A. W., & Malanda, B. (2018). IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Research and Clinical Practice, 138, 271–281. https://doi.org/10.1016/j.diabres.2018.02.023

Costa, F. O., Takenaka-Martinez, S., Cota, L. O. M., Ferreira, S. D., Silva, G. L. M., & Costa, J. E. (2012). Peri-implant disease in subjects with and without preventive maintenance: A 5-year follow-up. Journal of Clinical Periodontology, 39(2), 173–181. https://doi.org/10.1111/j.1600-051X.2011.01819.x

Cyprus, G. N., Overlin, J. W., Hotchkiss, K. M., Kandalam, S., & Olivares-Navarrete, R. (2018). Cigarette smoke increases pro-inflammatory markers and inhibits osteogenic differentiation in experimental exposure model. Acta Biomaterialia, 76, 308–318. https://doi.org/10.1016/j.actbio.2018.06.018

Derks, J., Schaller, D., Håkansson, J., Wennström, J. L., Tomasi, C., & Berglundh, T. (2016). Peri-implantitis—Onset and pattern of progression. Journal of Clinical Periodontology, 43(4), 383–388. https://doi.org/10.1111/jcpe.12535

Derks, J., & Tomasi, C. (2015). Peri-implant health and disease. A systematic review of current epidemiology. Journal of Clinical Periodontology, 42 Suppl 16, S158-171. https://doi.org/10.1111/jcpe.12334

Dreyer, H., Grischke, J., Tiede, C., Eberhard, J., Schweitzer, A., Toikkanen, S. E., Glöckner, S., Krause, G., & Stiesch, M. (2018). Epidemiology and risk factors of peri-implantitis: A systematic review. Journal of Periodontal Research, 53(5), 657–681. https://doi.org/10.1111/jre.12562

Esposito, M., Grusovin, M. G., & Worthington, H. V. (2012). Treatment of peri-implantitis: what interventions are effective? A Cochrane systematic review. European journal of oral implantology, 5 Suppl, S21–S41.

Ferreira, S. D., Martins, C. C., Amaral, S. A., Vieira, T. R., Albuquerque, B. N., Cota, L. O. M., Esteves Lima, R. P., & Costa, F. O. (2018). Periodontitis as a risk factor for peri-implantitis: Systematic review and meta-analysis of observational studies. Journal of Dentistry, 79, 1–10. https://doi.org/10.1016/j.jdent.2018.09.010

ITI Treatment Guide Volume 13 (2022). Prevention and Management of Peri-Implant Diseases.

Javed, F., Rahman, I., & Romanos, G. E. (2019). Tobacco-product usage as a risk factor for dental implants. Periodontology 2000, 81(1), 48–56. https://doi.org/10.1111/prd.12282

Kassebaum, N. J., Bernabé, E., Dahiya, M., Bhandari, B., Murray, C. J., & Marcenes, W. (2014). Global burden of severe periodontitis in 1990-2010: a systematic review and meta-regression. Journal of dental research, 93(11), 1045–1053. https://doi.org/10.1177/0022034514552491

Leite, F. R. M., Nascimento, G. G., Baake, S., Pedersen, L. D., Scheutz, F., & López, R. (2019). Impact of Smoking Cessation on Periodontitis: A Systematic Review and Meta-analysis of Prospective Longitudinal Observational and Interventional Studies. Nicotine & Tobacco Research: Official Journal of the Society for Research on Nicotine and Tobacco, 21(12), 1600–1608. https://doi.org/10.1093/ntr/nty147

Heitz-Mayfield, L., & Mombelli, A. (2014). The Therapy of Peri-implantitis: A Systematic Review. The International Journal of Oral & Maxillofacial Implants, 29(Supplement), 325–345. https://doi.org/10.11607/jomi.2014suppl.g5.3

Herrera, D., Berglundh, T., Schwarz, F., Chapple, I., Jepsen, S., Sculean, A., Kebschull, M., Papapanou, P. N., Tonetti, M. S., Sanz, M., & the EFP workshop participants and methodological consultant. (2023). Prevention and treatment of peri-implant diseases—The EFP S3 level clinical practice guideline. Journal of Clinical Periodontology, 50(S26), 4–76. https://doi.org/10.1111/jcpe.13823

GBD 2019 Tobacco Collaborators (2019). Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: A systematic analysis from the Global Burden of Disease Study 2019. (2021). Lancet (London, England), 397(10292), 2337–2360. https://doi.org/10.1016/S0140-6736(21)01169-7

Hill, A. B. (1949). Principles of medical statistics (Enlarged 9th edition). Lancet,The.

Javed, F., Rahman, I., & Romanos, G. E. (2019). Tobacco-product usage as a risk factor for dental implants. Periodontology 2000, 81(1), 48–56. https://doi.org/10.1111/prd.12282

Jepsen, S., Berglundh, T., Genco, R., Aass, A. M., Demirel, K., Derks, J., Figuero, E., Giovannoli, J. L., Goldstein, M., Lambert, F., Ortiz-Vigon, A., Polyzois, I., Salvi, G. E., Schwarz, F., Serino, G., Tomasi, C., & Zitzmann, N. U. (2015). Primary prevention of peri-implantitis: Managing peri-implant mucositis. Journal of Clinical Periodontology, 42 Suppl 16, S152-157. https://doi.org/10.1111/jcpe.12369

Karoussis, I. K., Salvi, G. E., Heitz-Mayfield, L. J. A., Brägger, U., Hämmerle, C. H. F., & Lang, N. P. (2003). Long-term implant prognosis in patients with and without a history of chronic periodontitis: A 10-year prospective cohort study of the ITI Dental Implant System. Clinical Oral Implants Research, 14(3), 329–339. https://doi.org/10.1034/j.1600-0501.000.00934.x

Kassebaum, N. J., Bernabé, E., Dahiya, M., Bhandari, B., Murray, C. J. L., & Marcenes, W. (2014). Global Burden of Severe Tooth Loss: A Systematic Review and Meta-analysis. Journal of Dental Research, 93(7 Suppl), 20S-28S. https://doi.org/10.1177/0022034514537828

Lalla, E., & Papapanou, P. N. (2011). Diabetes mellitus and periodontitis: A tale of two common interrelated diseases. Nature Reviews. Endocrinology, 7(12), 738–748. https://doi.org/10.1038/nrendo.2011.106

Lilienfeld, D. E., & Stolley, P. D. (1994). Foundations of Epidemiology. Oxford University Press.

Löe, H. (1993). Periodontal disease. The sixth complication of diabetes mellitus. Diabetes Care, 16(1), 329–334.

Monje, A., Catena, A., & Borgnakke, W. S. (2017). Association between diabetes mellitus/hyperglycaemia and peri-implant diseases: Systematic review and meta-analysis. Journal of Clinical Periodontology, 44(6), 636–648. https://doi.org/10.1111/jcpe.12724

Nathan, D. M., Kuenen, J., Borg, R., Zheng, H., Schoenfeld, D., Heine, R. J., & A1c-Derived Average Glucose Study Group (2008). Translating the A1C assay into estimated average glucose values. Diabetes care, 31(8), 1473–1478. https://doi.org/10.2337/dc08-0545

Nibali, L., Gkranias, N., Mainas, G., & Di Pino, A. (2022). Periodontitis and implant complications in diabetes. Periodontology 2000, 90(1), 88–105. https://doi.org/10.1111/prd.12451

Pereira, M. L., Carvalho, J. C., Peres, F., & Fernandes, M. H. (2010). Simultaneous effects of nicotine, acrolein, and acetaldehyde on osteogenic-induced bone marrow cells cultured on plasma-sprayed titanium implants. The International Journal of Oral & Maxillofacial Implants, 25(1), 112–122.

Pimentel, S. P., Fontes, M., Ribeiro, F. V., Corrêa, M. G., Nishii, D., Cirano, F. R., Casati, M. Z., & Casarin, R. C. V. (2018). Smoking habit modulates peri-implant microbiome: A case-control study. Journal of Periodontal Research, 53(6), 983–991. https://doi.org/10.1111/jre.12597

Reis, I. N. R. D., do Amaral, G. C. L. S., Hassan, M. A., Villar, C. C., Romito, G. A., Spin-Neto, R., & Pannuti, C. M. (2023). The influence of smoking on the incidence of peri-implantitis: A systematic review and meta-analysis. Clinical Oral Implants Research. https://doi.org/10.1111/clr.14066

Roccuzzo, A., Weigel, L., Marruganti, C., Imber, J. C., Ramieri, G., Sculean, A., Salvi, G. E., & Roccuzzo, M. (2023). Longitudinal assessment of peri-implant diseases in patients with and without history of periodontitis: A 20-year follow-up study. International journal of oral implantology (Berlin, Germany), 16(3), 211–222.

Roccuzzo, M., De Angelis, N., Bonino, L., & Aglietta, M. (2010). Ten-year results of a three-arm prospective cohort study on implants in periodontally compromised patients. Part 1: implant loss and radiographic bone loss. Clinical oral implants research, 21(5), 490–496. https://doi.org/10.1111/j.1600-0501.2009.01886.x

Roccuzzo, M., Bonino, F., Aglietta, M., & Dalmasso, P. (2012). Ten-year results of a three arms prospective cohort study on implants in periodontally compromised patients. Part 2: clinical results. Clinical oral implants research, 23(4), 389–395. https://doi.org/10.1111/j.1600-0501.2011.02309.x

Sayardoust, S., Omar, O., Norderyd, O., & Thomsen, P. (2017). Clinical, radiological, and gene expression analyses in smokers and non-smokers, Part 2: RCT on the late healing phase of osseointegration. Clinical Implant Dentistry and Related Research, 19(5), 901–915. https://doi.org/10.1111/cid.12514

Schwarz, F., Derks, J., Monje, A., & Wang, H. L. (2018). Peri‐implantitis. Journal of clinical periodontology, 45, S246-S266.

Sgolastra, F., Petrucci, A., Severino, M., Gatto, R., & Monaco, A. (2015). Smoking and the risk of peri-implantitis. A systematic review and meta-analysis. Clinical Oral Implants Research, 26(4), e62–e67. https://doi.org/10.1111/clr.12333

Stiesch, M., Grischke, J., Schaefer, P., & Heitz-Mayfield, L. J. A. (2023). Supportive care for the prevention of disease recurrence/progression following peri-implantitis treatment: A systematic review. Journal of clinical periodontology, 50 Suppl 26, 113–134. https://doi.org/10.1111/jcpe.13822

Tan, S. J., Baharin, B., Nabil, S., Mohd, N., & Zhu, Y. (2021). Does glycemic control have a dose-response relationship with implant outcomes? A comprehensive systematic review and meta-analysis. The Journal of Evidence-based Dental Practice, 21(2), 101543. https://doi.org/10.1016/j.jebdp.2021.101543.

Tsigarida, A. A., Dabdoub, S. M., Nagaraja, H. N., & Kumar, P. S. (2015). The Influence of Smoking on the Peri-Implant Microbiome. Journal of Dental Research, 94(9), 1202–1217. https://doi.org/10.1177/0022034515590581

Turri, A., Rossetti, P. H. O., Canullo, L., Grusovin, M. G., & Dahlin, C. (2016). Prevalence of Peri-implantitis in Medically Compromised Patients and Smokers: A Systematic Review. The International Journal of Oral & Maxillofacial Implants, 31(1), 111–118. https://doi.org/10.11607/jomi.4149

Research

My life beyond research: Behnam Akhavan

In this new feature the ITI Blog takes a 360° look at the personal and professional lives of individual researchers who have received ITI funding. In this issue, we interview Dr. Behnam Akhavan, Plasma Bio-Engineering Group Leader at the school of Engineering, Hunter Medical Research Institute (HMRI) – University of Newcastle.

Read More »
ITI World Symposium 2024

ITI World Symposium 2024

Early bird ends Dec 1st, 2023

Register now and save up to USD 250!